Rh-Oligopeptide-33

INCI: RH-OLIGOPEPTIDE-33

CAS Number
Not specifically assigned
Function
Skin conditioning
Safety Rating
MODERATE

Regulatory Status

๐Ÿ‡ช๐Ÿ‡บ EU Status prohibited
๐Ÿ‡บ๐Ÿ‡ธ US Status prohibited
US Notes Not specifically prohibited

For full compliance data across 55 jurisdictions, use the Substance Compliance tool.

Safety Data

Margin of Safety (MoS)
adequate
Dermal Absorption
negligible
Sensitization
low

Calculate MoS for your specific formulation with the MoS Calculator.

Expert Verdict

EU-banned. Very limited independent toxicological data available. Newer INCI entry with minimal published safety assessments. Requires robust supplier CoA and safety dossier.

โš ๏ธ
Concern Level: High

Frequently Asked Questions

Is Rh-Oligopeptide-33 safe in cosmetics?

EU-banned. Very limited independent toxicological data available. Newer INCI entry with minimal published safety assessments. Requires robust supplier CoA and safety dossier. The EU classifies Rh-Oligopeptide-33 as "prohibited". Safety rating: MODERATE.

Is Rh-Oligopeptide-33 allowed in the EU?

Rh-Oligopeptide-33 EU regulatory status: prohibited. This is based on EU Regulation 1223/2009 and its amendments.

What does Rh-Oligopeptide-33 do in cosmetics?

Rh-Oligopeptide-33 functions as: Skin conditioning. It is classified as a cosmetic ingredient in our database. CAS number: Not specifically assigned.

What is the Margin of Safety for Rh-Oligopeptide-33?

adequate The Margin of Safety (MoS) is calculated using SCCS methodology. A MoS above 100 is generally considered safe. Use the MoS Calculator tool to calculate MoS for your specific formulation and product category.

๐Ÿ“ฑ

Is Rh-Oligopeptide-33 in Your Products?

Scan any product label with Piro โ€” our free ingredient scanner. Point your camera at the ingredients list and get instant safety scores for every ingredient.

Try Piro Free โ†’

Analyze Your Full Ingredient List

Paste any INCI list into the Decoder for instant safety analysis, or calculate the Margin of Safety for Rh-Oligopeptide-33 in your formulation.